Syneos Health, Inc. / Fundamentals

    Income statement

    Net revenue
    €4.65B
    Cost of goods sold
    €3.62B
    Gross profit
    €1.03B
    SG&A expenses
    €525.17M
    R&D expenses
    €0.00
    EBITDA
    €471.01M
    D&A
    €211.72M
    EBIT
    €249.42M
    Interest expenses
    €95.58M
    EBT
    €71.12M
    Tax expenses
    €10.01M
    Net income
    €61.11M

    Cash flow statement

    Net deferred tax
    -€31.49M
    Non-cash items
    €29.18M
    Changes in working capital
    -€105.40M
    Operating cash flow
    €217.02M
    Capex
    €78.09M
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€86.74M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €30.60M
    Debt repayment
    €0.00
    Other financing cash flow
    -€133.61M
    Net financing cash flow
    -€153.14M
    Foreign exchange effects
    €2.52M
    Net change in cash
    -€20.34M
    Cash at end of period
    €70.59M
    Free cash flow
    €295.11M

    Balance sheet

    Cash and cash equivalents
    €70.50M
    Cash and short-term investments
    €70.50M
    Total receivables
    €1.46B
    Inventory
    €93.52K
    Other current assets
    €145.81M
    Total current assets
    €1.67B
    Property, plant & equipment
    €285.41M
    Goodwill
    €4.21B
    Intangible assets
    €522.04M
    Long-term investments
    €0.00
    Other non-current assets
    €183.03M
    Total non-current assets
    €5.25B
    Total assets
    €6.93B
    Accounts payable
    €117.56M
    Short-term debt
    €58.58M
    Other current liabilities
    €530.20M
    Total current liabilities
    €1.40B
    Long-term debt
    €2.43B
    Deferred tax liabilities
    €59.49M
    Other non-current liabilities
    €49.92M
    Total non-current liabilities
    €2.53B
    Total liabilities
    €3.93B
    Common stock
    €889.75K
    Retained earnings
    €82.66M
    Other equity
    -€90.62M
    Total equity
    €3.00B
    Total liabilities and shareholders' equity
    €6.93B

    Company information

    Market capitalization
    €3.80B
    Employees
    29K
    Enterprise Value
    €7.24B

    Company ratios

    Gross margin
    22.1% Much worse than peer group: 45.3%
    EBITDA margin
    10.1% Much better than peer group: -28.6%
    EBIT margin
    5.4% Much better than peer group: -38.8%
    EBT margin
    1.5% Much better than peer group: -42.9%
    Net margin
    1.3% Much better than peer group: -44.7%
    ROE
    2.0% Much worse than peer group: 106.1%
    ROA
    0.9% Even with peer group: 1.9%
    Asset turnover
    67.1% Worse than peer group: 74.4%
    FCF margin
    3.0% Much better than peer group: -29.0%
    FCF yield
    3.7%
    Efficiency ratio
    89.9%
    Net sales per employee
    €161.62K
    Net income per employee
    €2.12K

    Notifications